Page last updated: 2024-11-05

tizanidine and Dyskinesia Syndromes

tizanidine has been researched along with Dyskinesia Syndromes in 3 studies

tizanidine: RN given refers to parent cpd; structure
tizanidine : 2,1,3-Benzothiadiazole substituted at C-4 by a Delta(1)-imidazolin-2-ylamino group and at C-4 by a chloro group. It is an agonist at alpha2-adrenergic receptor sites.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Niederhofer, H1
Benecke, R1
Patejdl, R1
Ringwald, E1
Campean, SJ1
Gerstenbrand, F1
Lorincz, A1
Lörincz, P1
Ludin, HP1

Reviews

1 review available for tizanidine and Dyskinesia Syndromes

ArticleYear
[New therapies for spastic movement disorders].
    MMW Fortschritte der Medizin, 2009, Volume: 151 Suppl 3

    Topics: Administration, Oral; Baclofen; Botulinum Toxins, Type A; Cannabinoids; Clonidine; Diazepam; Humans;

2009

Trials

1 trial available for tizanidine and Dyskinesia Syndromes

ArticleYear
[Clinical experiences with a new muscle relaxant (DS 103-282 Sandoz) (author's transl)].
    Der Nervenarzt, 1977, Volume: 48, Issue:7

    Topics: Adult; Clinical Trials as Topic; Clonidine; Drug Evaluation; Drug Tolerance; Female; Humans; Male; M

1977

Other Studies

1 other study available for tizanidine and Dyskinesia Syndromes

ArticleYear
Tizanidine is not effective treating EPMS.
    Medical hypotheses, 2018, Volume: 116

    Topics: Adolescent; Adult; Basal Ganglia Diseases; Biperiden; Cholinergic Antagonists; Clonidine; Clopenthix

2018